News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Depression Drug Edronax Ineffective, May Be Harmful, Study in British Medical Journal Says


10/13/2010 6:37:24 AM

LONDON, Oct 13 (Reuters) - Pfizer's (PFE.N) antidepressant reboxetine is an "ineffective and potentially harmful" drug and published data on it overestimates the benefits and underplays the risks, a study by German researchers said on Wednesday.

Read at Guardian
Read at BBC News
Read at Reuters
Read at Bloomberg

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES